Patient Advocates’ Comments to the FDA on Metals in Implants Immunology Devices Panel of the Medical Devices Advisory Committee; Notice...

Jonesboro resident Geraldine Robinson is one of millions of Americans who use an implanted medical device to improve, and possibly extend...

We believe that there is no need for the proposed Right To Try Legislation (RTT). A pathway to such access already exists through the FDA’s

Wendy Dolin believes that a drug her husband was taking, an antidepressant called Paxil, played a role in his suicide by triggering a side e

“You have a situation where patients think they want to take a risk and don’t necessarily understand what risk they are taking," said D

The chemical industry, while paying “lip service” to the new law, which it publicly supported, is now trying to “slow walk implementation an

Women using the "permanent contraceptive" device called Essure are experiencing health problems, such as bad toothaches & head

“In addition to risks to patients, these FDA actions mean even less information about the devices that will be available to doctors and thei

“It often takes months or even years for the F.D.A. to detect patterns of failure,” said Jack Mitchell, director of health policy for the Na

Doctors who accept visits and gifts from pharmaceutical reps are more likely to be biased in which drugs they prescribe.

In accomplishing the goal of developing a nuanced understanding of the patient experience by disease, it is critical that any future Office

“FDA approval is based on evidence — provided by the company that makes the medical product — that the benefits of the product outweigh the

Dr Reed, a mother of six, underwent the hysterectomy at Brigham and Women's Hospital in Boston, Massachusetts, to remove fibroid tumors.

“I have never known Congress that enthusiastically cut NIH funding,” she said. But she’s less sanguine about the fate of the Centers for Dis

Women who have had the lymphoma say that the attention is long overdue, that too few women have been informed of the risk and that those wit

“All too often, patients and clinicians mistakenly view FDA approval as [an] indication that a product is fully safe and effective,” he said

"None of us here are anti-drug. That's not the issue," Dolin added, "but we are patient advocates and we hope that people

There is an American tendency to equate scientific review with bureaucratic delay. But it is this review that distinguishes what works from

Next month, the Food and Drug Administration is likely to miss another target date for implementing a rule to improve generic drug safety. I

Legislation before Congress seeks to grant all terminally ill patients the “Right to Try” experimental therapies once approved alternatives